A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging
NCT ID: NCT00613262
Last Updated: 2012-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2012-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Narrow Band Imaging Colon Polyp Study
NCT00614770
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
NCT01214031
Practice-Based Learning to Predict Polyp Histology at Colonoscopy
NCT01638091
Computer-based Classification of Colorectal Polyps Using Narrow-band Imaging
NCT01262248
White Light vs Narrow Band Imagingin the Diagnosis of Right Sided Colonic Polyps in Asymptomatic Subjects Undergoing Screening Colonoscopy
NCT05935124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrow Band Imaging
Narrow Band Imaging Colonoscope offers an alternative lightsource to view colon polyps in real time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the ability to provide informed consent
Exclusion Criteria
* prior history of colon cancer
* history of inflammatory bowel disease
* use of anti-platelet agents or anticoagulants that precludes removal of polyps during the procedure
* poor general condition or any other reason to avoid prolonged procedure time
* history of polyposis syndrome or Hereditary Non-polyposis colon cancer
* inability to give informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Midwest Biomedical Research Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amit Rastogi
Principal Investagator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amit Rastogi, MD
Role: PRINCIPAL_INVESTIGATOR
Kansas City VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kansas City VA Medical Center
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00371
Identifier Type: -
Identifier Source: secondary_id
AR0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.